Levodopa dimethyl-substituted diester prodrugs pharmaceutical,
compositions comprising levodopa dimethyl-substituted diester prodrugs,
and methods of using such prodrugs and pharmaceutical compositions for
treating diseases such as Parkinson's disease are provided.